down arrow

Simcere Pharmaceutical Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: HK0000658531
HKD
13.09
-0.55 (-4.03%)

Dec 12

HKG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
Net Sales
7,301.61
7,348.34
6,025.71
5,066.42
5,711.15
5,346.87
4,460.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
7,301.61
7,348.34
6,025.71
5,066.42
5,711.15
5,346.87
4,460.03
Raw Material Cost
1,794.13
1,537.61
1,301.61
1,011.24
1,111.81
988.90
733.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
2,654.56
2,485.40
1,765.76
1,300.87
1,075.15
747.92
600.62
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
38.20
40.01
85.39
150.27
131.48
56.30
67.39
Selling and Distribution Expenses
3,154.55
3,236.32
2,872.43
2,197.04
2,626.95
2,929.10
2,765.17
Other Expenses
-96.55
-51.56
-14.37
-16.79
-44.06
-30.38
-43.97
Total Expenditure (Excl Depreciation)
6,675.94
6,783.69
5,881.49
4,491.54
4,504.82
4,418.37
3,726.48
Operating Profit (PBDIT) excl Other Income
625.7
564.6
144.2
574.9
1206.3
928.5
733.6
Other Income
281.78
322.64
1,727.08
639.20
161.21
230.13
-92.76
Operating Profit (PBDIT)
1,225.68
1,158.65
2,131.58
1,350.75
1,551.81
1,300.76
760.89
Interest
38.20
40.01
85.39
150.27
131.48
56.30
67.39
Exceptional Items
-36.31
242.97
0.00
-29.95
0.00
0.00
0.00
Gross Profit (PBDT)
5,507.48
5,810.73
4,724.11
4,055.18
4,599.34
4,357.97
3,727.04
Depreciation
342.10
329.01
303.48
249.83
184.27
142.14
120.09
Profit Before Tax
809.07
1,032.59
1,742.71
920.70
1,236.06
1,102.32
573.41
Tax
28.83
-47.07
-117.05
158.22
88.66
231.39
169.36
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
789.81
1,084.70
1,816.37
752.35
1,138.03
869.02
404.05
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
789.81
1,084.70
1,816.37
752.35
1,138.03
869.02
404.05
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.90
-4.81
-9.85
-5.90
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
788.91
1,079.89
1,806.52
746.45
1,138.03
869.02
404.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
7,952.27
8,001.50
7,874.16
6,286.01
1,656.04
1,784.81
2,135.77
Earnings per share (EPS)
0.3
0.41
0.7
0.31
0.44
0.33
0.15
Diluted Earnings per share
0.3
0.41
0.7
0.31
0.44
0.33
0.15
Operating Profit Margin (Excl OI)
8.24%
6.9%
1.68%
9.11%
21.12%
17.37%
16.45%
Gross Profit Margin
15.77%
18.53%
33.96%
23.1%
24.87%
23.27%
15.55%
PAT Margin
10.82%
14.76%
30.14%
14.85%
19.93%
16.25%
9.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2023 is -0.64% vs 21.95% in Dec 2022

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2023 is -26.95% vs -40.22% in Dec 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2023 is 12.91% vs 106.67% in Dec 2022

stock-summary

Interest

YoY Growth in year ended Dec 2023 is -4.50% vs -53.16% in Dec 2022

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2023 has improved from Dec 2022

Compare Annual Results Of Simcere Pharmaceutical Group Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
7,301.61
20,024.62
-12,723.01
-63.54%
Other Operating Income
0.00
0.00
0.00
Total Operating income
7,301.61
20,024.62
-12,723.01
-63.54%
Raw Material Cost
1,794.13
9,776.33
-7,982.20
-81.65%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
2,654.56
2,628.12
26.44
1.01%
Power Cost
0
0
0.00
Manufacturing Expenses
38.20
219.94
-181.74
-82.63%
Selling and Distribution Expenses
3,154.55
8,205.02
-5,050.47
-61.55%
Other Expenses
-96.55
-209.04
112.49
53.81%
Total Expenditure (Excl Depreciation)
6,675.94
18,738.97
-12,063.03
-64.37%
Operating Profit (PBDIT) excl Other Income
625.67
1,285.65
-659.98
-51.33%
Other Income
281.78
315.09
-33.31
-10.57%
Operating Profit (PBDIT)
1,225.68
2,819.93
-1,594.25
-56.54%
Interest
38.20
219.94
-181.74
-82.63%
Exceptional Items
-36.31
-23.60
-12.71
-53.86%
Gross Profit (PBDT)
5,507.48
10,248.30
-4,740.82
-46.26%
Depreciation
342.10
1,219.19
-877.09
-71.94%
Profit Before Tax
809.07
1,357.19
-548.12
-40.39%
Tax
28.83
-189.55
218.38
115.21%
Provisions and contingencies
0
0
0.00
Profit After Tax
789.81
1,420.14
-630.33
-44.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
789.81
1,420.14
-630.33
-44.39%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.90
122.51
-123.41
-100.73%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
788.91
1,542.65
-753.74
-48.86%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
7,952.27
23,297.42
-15,345.15
-65.87%
Earnings per share (EPS)
0.30
0.28
0.02
7.14%
Diluted Earnings per share
0.30
0.28
0.02
7.14%
Operating Profit Margin (Excl OI)
8.24%
6.42%
0.00
1.82%
Gross Profit Margin
15.77%
12.87%
0.00
2.90%
PAT Margin
10.82%
7.09%
0.00
3.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 730.16 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is -0.64% vs 21.95% in Dec 2022

Annual - Consolidate Net Profit
Consolidate Net Profit 78.89 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is -26.95% vs -40.22% in Dec 2022

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 94.39 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 12.91% vs 106.67% in Dec 2022

Annual - Interest
Interest 3.82 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is -4.50% vs -53.16% in Dec 2022

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.24%
in Dec 2023

Figures in %
stock-summary

YoY Growth in year ended Dec 2023 has improved from Dec 2022

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."